PEOPLE - Geron (US) makes appointment:
This article was originally published in Clinica
Dr Thomas Okarma has been appointed president and CEO of Geron, a US developer of diagnostics for cancer and age-related degenerative diseases. The former vice-president of research and development succeeds Ronald Eastman who will remain a director.
You may also be interested in...
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.
The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.